Targeting the DNA Damage Response in Cancer-Reference-Cited by-同舟云学术

Targeting the DNA Damage Response in Cancer

Published:2015-11 Issue:4 Volume:60 Page:547-560
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

O’Connor Mark J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference123 articles.

1. Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1;Aarts;Cancer Discov.,2012

2. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer;Abkevich;Br. J. Cancer,2012

3. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy;Al-Ahmadie;Cancer Discov.,2014

4. Role of MTH1 (NUTD1) in cancer cell survival;Alwan;Proceedings of the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,2015

5. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair;Ashworth;J. Clin. Oncol.,2008

Cited by 1135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Celastrol induces DNA damage and cell death in BCR-ABL T315I-mutant CML by targeting YY1 and HMCES;Phytomedicine;2024-11

3. Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy;Journal of Controlled Release;2024-10

4. Fucoidan based polymeric nanoparticles encapsulating epirubicin: A novel and effective chemotherapeutic formulation against colorectal cancer;International Journal of Pharmaceutics;2024-10

5. Clinical and radiological pattern of olaparib-induced interstitial lung disease;BMC Pulmonary Medicine;2024-09-13